Unfortunately, a study published in JAMA, found that the use of certain diabetes or weight loss medications (i.e., GLP-1 agonists such as Ozempic, Mounjaro, Wegovy, or Rybelsus) may be associated with an increased risk of developing stomach paralysis or gastroparesis
So, while you shouldnt get discouraged if you dont see immediate results in the first few weeks, its common to observe noticeable enhancements each month of Semaglutide GLP-1 treatment
Gas Chromatography-Mass Spectrometry (GC-MS) : GC-MS is another powerful tool for acylcarnitine analysis, particularly for volatile or less polar acylcarnitine derivatives
Tested on dermatological PDRN-based skin booster injection
The GLP-1 story started with blood sugar and expanded to weight loss